JUDITH ERIKA CSANKY MD
Prescription History 1598843039
Internal Medicine - Gastroenterology in Twin Falls, ID

NPI Status: Active since November 01, 2006

Contact Information

1411 FALLS AVE E STE 1151
TWIN FALLS, ID
ZIP 83301
Phone: (208) 933-4277

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for JUDITH ERIKA CSANKY MD, an active Gastroenterology specialist practicing in Twin Falls, ID. Our medical registry currently tracks 15 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 484 documented patient claims. Among these therapy options, the most frequently utilized medication is Pantoprazole Sodium, which accounts for 121 claims alone.


Azathioprine

Generic Formulation: AzathioprineSpecialty: Gastroenterology
Provider Metrics Summary
Total Claims 11
30-Day Fills 11.0
Days Supply 330
ID State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills51.2
Peer Average Days Supply1,520
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 57.7% less volume than the regional standard for practitioners inside ID. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $47.08 across this reporting matrix range.

Provider Avg Cost Per Claim

$4.28

State Avg Cost Per Claim

$70.26

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)

Therapeutic Applications

Azathioprine is used to prevent organ rejection in people who have received a kidney transplant. It is usually taken along with other medications to allow your new kidney to function normally. Azathioprine is also used to treat rheumatoid arthritis. In this condition, the body's defense system (immune system) attacks healthy joints. Azathioprine belongs to a class of drugs known as immunosuppressants. It works by weakening the immune system to help your body accept the new kidney as if it were your own (in the case of an organ transplant) or to prevent further damage to your joints (in the case of rheumatoid arthritis). Talk to your doctor about the risks and benefits of azathioprine, especially when used by children and young adults.

Budesonide Dr

Generic Formulation: BudesonideSpecialty: Gastroenterology
Provider Metrics Summary
Total Claims 25
30-Day Fills 31.0
Days Supply 930
ID State Average Benchmarks
Peer Average Claims20.0
Peer Average 30-Day Fills31.9
Peer Average Days Supply933
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across ID. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,498.91 across this reporting matrix range.

Provider Avg Cost Per Claim

$139.96

State Avg Cost Per Claim

$195.97

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A glucocorticoid used in the management of ASTHMA, the treatment of various skin disorders, and allergic RHINITIS.

Therapeutic Applications

Budesonide is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma. This medication belongs to a class of drugs known as corticosteroids. It works directly in the lungs to make breathing easier by reducing the irritation and swelling of the airways. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler as prescribed.

Dicyclomine Hcl

Generic Formulation: Dicyclomine HclSpecialty: Gastroenterology
Provider Metrics Summary
Total Claims 33
30-Day Fills 47.0
Days Supply 1,318
ID State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills27.8
Peer Average Days Supply730
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 50.0% more claims than the standard regional baseline profile for ID. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $792.28 across this reporting matrix range.

Provider Avg Cost Per Claim

$24.01

State Avg Cost Per Claim

$21.89

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Famotidine

Generic Formulation: FamotidineSpecialty: Gastroenterology
Provider Metrics Summary
Total Claims 23
30-Day Fills 41.3
Days Supply 1,240
ID State Average Benchmarks
Peer Average Claims37.0
Peer Average 30-Day Fills72.3
Peer Average Days Supply2,137
Conservative Utilization

This provider writes prescriptions for this formulation 37.8% less frequently than the standard regional baseline metric for practitioners inside ID. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $439.51 across this reporting matrix range.

Provider Avg Cost Per Claim

$19.11

State Avg Cost Per Claim

$16.02

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.

Therapeutic Applications

Famotidine is used to treat ulcers of the stomach and intestines and to prevent intestinal ulcers from coming back after they have healed. This medication is also used to treat certain stomach and throat (esophagus) problems (such as erosive esophagitis, gastroesophageal reflux disease-GERD, Zollinger-Ellison syndrome). It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as cough that doesn't go away, stomach pain, heartburn, and difficulty swallowing. Famotidine belongs to a class of drugs known as H2 blockers. This medication is also available without a prescription. It is used to prevent and treat heartburn and other symptoms caused by too much acid in the stomach (acid indigestion). If you are taking this medication for self-treatment, it is important to read the manufacturer's package instructions carefully so you know when to consult your doctor or pharmacist.

Gavilyte-G

Generic Formulation: Peg3350/Sod Sulf,bicarb,cl/KclSpecialty: Gastroenterology
Provider Metrics Summary
Total Claims 41
30-Day Fills 41.0
Days Supply 65
ID State Average Benchmarks
Peer Average Claims44.0
Peer Average 30-Day Fills45.0
Peer Average Days Supply110
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across ID. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $666.30 across this reporting matrix range.

Provider Avg Cost Per Claim

$16.25

State Avg Cost Per Claim

$15.54

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

PEG (polyethylene glycol) with electrolyte is used to clean out the intestines before certain bowel exam procedures such as colonoscopy or barium enema X-rays. It is a laxative that works by drawing large amounts of water into the colon. This effect results in watery bowel movements. Clearing stool from the intestines helps your doctor to better examine the intestines during your procedure.

Linzess

Generic Formulation: LinaclotideSpecialty: Gastroenterology
Provider Metrics Summary
Total Claims 27
30-Day Fills 37.0
Days Supply 1,110
ID State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills31.8
Peer Average Days Supply927
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across ID. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $19,455.66 across this reporting matrix range.

Provider Avg Cost Per Claim

$720.58

State Avg Cost Per Claim

$644.89

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

See also Warning section. Linaclotide is used to treat certain types of bowel problems (irritable bowel syndrome with constipation, chronic idiopathic constipation). It works by increasing fluid in your intestines and helping speed up movement of food through the gut. Linaclotide may improve stool texture and lessen symptoms such as bloating, abdominal pain/discomfort, straining, and feelings of incomplete bowel movements.

Mesalamine Er

Generic Formulation: MesalamineSpecialty: Gastroenterology
Provider Metrics Summary
Total Claims 16
30-Day Fills 16.0
Days Supply 480
ID State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills31.4
Peer Average Days Supply933
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across ID. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $5,367.08 across this reporting matrix range.

Provider Avg Cost Per Claim

$335.44

State Avg Cost Per Claim

$507.44

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)

Therapeutic Applications

This medication is used to treat a certain bowel disease (ulcerative colitis). It helps to reduce symptoms of ulcerative colitis such as diarrhea, rectal bleeding, and stomach pain. Mesalamine belongs to a class of drugs known as aminosalicylates. It works by decreasing swelling in the colon.

Omeprazole

Generic Formulation: OmeprazoleSpecialty: Gastroenterology
Provider Metrics Summary
Total Claims 40
30-Day Fills 68.0
Days Supply 2,040
ID State Average Benchmarks
Peer Average Claims101.0
Peer Average 30-Day Fills226.1
Peer Average Days Supply6,742
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 60.4% less volume than the regional standard for practitioners inside ID. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $458.38 across this reporting matrix range.

Provider Avg Cost Per Claim

$11.46

State Avg Cost Per Claim

$14.05

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.

Therapeutic Applications

Omeprazole is used to treat certain stomach and esophagus problems (such as acid reflux, ulcers). It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as heartburn, difficulty swallowing, and cough. This medication helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Omeprazole belongs to a class of drugs known as proton pump inhibitors (PPIs). If you are self-treating with this medication, over-the-counter omeprazole products are used to treat frequent heartburn (occurring 2 or more days a week). Since it may take 1 to 4 days to have full effect, these products do not relieve heartburn right away. For over-the-counter products, carefully read the package instructions to make sure the product is right for you. Check the ingredients on the label even if you have used the product before. The manufacturer may have changed the ingredients. Also, products with similar brand names may contain different ingredients meant for different purposes. Taking the wrong product could harm you.

Ondansetron Odt

Generic Formulation: OndansetronSpecialty: Gastroenterology
Provider Metrics Summary
Total Claims 73
30-Day Fills 77.0
Days Supply 553
ID State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills26.8
Peer Average Days Supply275
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 180.8% higher than the standard regional baseline profile for ID. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,137.03 across this reporting matrix range.

Provider Avg Cost Per Claim

$15.58

State Avg Cost Per Claim

$18.08

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Therapeutic Applications

This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. It is also used to prevent and treat nausea and vomiting after surgery. Ondansetron works by blocking one of the body's natural substances (serotonin) that causes vomiting.

Pantoprazole Sodium

Generic Formulation: Pantoprazole SodiumSpecialty: Gastroenterology
Provider Metrics Summary
Total Claims 121
30-Day Fills 194.2
Days Supply 5,792
ID State Average Benchmarks
Peer Average Claims51.0
Peer Average 30-Day Fills104.8
Peer Average Days Supply3,114
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 137.3% higher than the standard regional baseline profile for ID. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,861.10 across this reporting matrix range.

Provider Avg Cost Per Claim

$15.38

State Avg Cost Per Claim

$16.56

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.

Therapeutic Applications

Pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). It works by decreasing the amount of acid your stomach makes. This medication relieves symptoms such as heartburn, difficulty swallowing, and cough. It helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Pantoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs).

Peg-3350 And Electrolytes

Generic Formulation: Peg3350/Sod Sulf,bicarb,cl/KclSpecialty: Gastroenterology
Provider Metrics Summary
Total Claims 12
30-Day Fills 12.0
Days Supply 16
ID State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills29.6
Peer Average Days Supply36
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 58.6% less volume than the regional standard for practitioners inside ID. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $240.00 across this reporting matrix range.

Provider Avg Cost Per Claim

$20.00

State Avg Cost Per Claim

$14.93

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

PEG (polyethylene glycol) with electrolyte is used to clean out the intestines before certain bowel exam procedures such as colonoscopy or barium enema X-rays. It is a laxative that works by drawing large amounts of water into the colon. This effect results in watery bowel movements. Clearing stool from the intestines helps your doctor to better examine the intestines during your procedure.

Propranolol Hcl

Generic Formulation: Propranolol HclSpecialty: Gastroenterology
Provider Metrics Summary
Total Claims 13
30-Day Fills 13.0
Days Supply 390
ID State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills41.7
Peer Average Days Supply1,221
Conservative Utilization

This provider writes prescriptions for this formulation 45.8% less frequently than the standard regional baseline metric for practitioners inside ID. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $315.24 across this reporting matrix range.

Provider Avg Cost Per Claim

$24.25

State Avg Cost Per Claim

$26.04

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This formulation of propranolol is used for infants and children to treat a certain benign tumor (proliferating infantile hemangioma). It helps to shrink the tumor. Propranolol belongs to a class of drugs known as beta blockers.

Sod Sulf-Potass Sulf-Mag Sulf

Generic Formulation: Sodium, Potassium,mag SulfatesSpecialty: Gastroenterology
Provider Metrics Summary
Total Claims 26
30-Day Fills 26.0
Days Supply 41
ID State Average Benchmarks
Peer Average Claims30.0
Peer Average 30-Day Fills30.5
Peer Average Days Supply48
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across ID. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,936.06 across this reporting matrix range.

Provider Avg Cost Per Claim

$74.46

State Avg Cost Per Claim

$80.06

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Sodium/potassium/magnesium sulfate solution is used to clean out the intestines before a certain bowel exam procedure (colonoscopy). It is a laxative that works by drawing large amounts of water into the colon. This causes watery bowel movements. Clearing stool from the intestines helps your doctor to better examine the intestines during your procedure.

Suprep

Generic Formulation: Sodium, Potassium,mag SulfatesSpecialty: Gastroenterology
Provider Metrics Summary
Total Claims 11
30-Day Fills 11.0
Days Supply 17
ID State Average Benchmarks
Peer Average Claims85.0
Peer Average 30-Day Fills87.3
Peer Average Days Supply183
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 87.1% less volume than the regional standard for practitioners inside ID. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,248.70 across this reporting matrix range.

Provider Avg Cost Per Claim

$113.52

State Avg Cost Per Claim

$110.95

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Sodium/potassium/magnesium sulfate solution is used to clean out the intestines before a certain bowel exam procedure (colonoscopy). It is a laxative that works by drawing large amounts of water into the colon. This causes watery bowel movements. Clearing stool from the intestines helps your doctor to better examine the intestines during your procedure.

Zenpep

Generic Formulation: Lipase/Protease/AmylaseSpecialty: Gastroenterology
Provider Metrics Summary
Total Claims 12
30-Day Fills 19.1
Days Supply 573
ID State Average Benchmarks
Peer Average Claims16.0
Peer Average 30-Day Fills18.1
Peer Average Days Supply435
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across ID. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $27,448.59 across this reporting matrix range.

Provider Avg Cost Per Claim

$2,287.38

State Avg Cost Per Claim

$1,566.54

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication contains digestive enzymes to help break down and digest fats, starch, and proteins in food. It is used in conditions where the pancreas cannot make or does not release enough digestive enzymes into the small intestines to digest the food (conditions such as chronic pancreatitis, cystic fibrosis, cancer of the pancreas, post-pancreatectomy, post-gastrointestinal bypass surgery).

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like JUDITH ERIKA CSANKY MD provides transparency into local medical care patterns within Twin Falls, ID.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Gastroenterology** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.